SRI International's in-house CRO has opened up a new Phase I center, expanding its footprint in the market for early-stage research. The new facility, in Plymouth, MI, is a 9,400-square-foot space within the Michigan Life Science Innovation Center, giving SRI Biosciences the capacity to conduct Phase I studies of new medicines and medical devices. More